GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Future of diagnosing and monitoring nonalcoholic fatty liver disease/nonalcoholic steatohepatitis could be noninvasive, says GlobalData

Liver fibrosis is a key characteristic that represents the severity of liver illnesses and is an important factor that helps forecast the progression of liver disorders toward cirrhosis. Although liver biopsies are currently considered to be the gold standard for the diagnosis and histological assessment of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH), they are not […]
Read more

Nubeqa approval to boost Bayer’s presence in prostate cancer market in Japan, says GlobalData

Following the news that Bayer’s androgen receptor inhibitor Nubeqa (darolutamide) in combination with androgen deprivation therapy (ADT) and docetaxel has been approved by Japan’s Ministry of Health, Labor and Welfare (MHLW) for use in patients with metastatic prostate cancer; James Donagher, Oncology & Hematology Analyst at GlobalData, offers his view: “Due to Japan’s ageing population, […]
Read more

India card payments market to grow by 23.6% in 2023, forecasts GlobalData

India’s card payments market is set to grow by 23.6% to reach INR26.9 trillion ($361.6 billion) in 2023, driven by rising consumer spending, says GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that card payments value in India registered a strong growth of 26.7% in 2022, supported by improving economic conditions. […]
Read more

Singapore’s PayNow linkage to help position India’s UPI as global payment brand, reveals GlobalData

India has registered a significant acceleration in the digital payments space in the last few years, with Unified Payments Interface (UPI), the country’s instant payment scheme, alone registering a 75.9% growth in 2022 to reach INR126 trillion ($1.5 trillion). Against this backdrop, UPI’s integration with Singapore’s instant payment scheme – PayNow will further expand its […]
Read more

3D printing in medical devices set to become $4 billion industry by 2026, forecasts GlobalData

3D printing complements traditional manufacturing by offering new opportunities for personalization and small-batch production of complicated parts. In medical devices, this allows for customized devices uniquely suited to patients, improving fit, comfort, and outcomes while reducing the risk of complications. Given its advantages, the medical 3D printing market is forecast to grow from just over […]
Read more

GlobalData Names PaaS Leaders: AWS, IBM, Microsoft, and Red Hat for Platforms that Adapt to New DevOps Concerns

The platform-as-a-service (PaaS) market segment continues to evolve to modernize new and existing apps by leveraging integration/API, intelligent automation, observability/FinOps, and AI/ML, including generative AI chatbots ChatGPT eventually. In its assessment of this marketplace, GlobalData, a leading data and analytics company, says that AWS, IBM, Microsoft, and Red Hat are best positioned to succeed in […]
Read more

Insurers facing business interruption claim lawsuits could lose business due to hampered reputations, says GlobalData

Following the news that insurers including Aviva and Liberty Mutual are all being pursued over failing to settle COVID-19-related business interruption (BI) claims; Benjamin Hatton, Associate Insurance Analyst at GlobalData, offers his view: “Business interruption cover is a complex policy, with a crisis such as a coronavirus pandemic highlighting the ambiguity in policy wording that […]
Read more
1 121 122 123 124 125 136